Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population-based cohort study. (PubMed, Alzheimers Dement) - Oct 12, 2026 - "Initiation of nilotinib, but not imatinib or dasatinib, was associated with a significantly lower NDD incidence relative to general population comparators."
Journal • Chronic Myeloid Leukemia • CNS Disorders • Hematological Malignancies • Leukemia • Oncology
|
|
Enoch Yi-Tung Chen; Felix Wittström; Iris Blotenberg; Torsten Dahlén
|